Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

351 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
K-ras mutations and benefit from cetuximab in advanced colorectal cancer.
Karapetis CS, Khambata-Ford S, Jonker DJ, O'Callaghan CJ, Tu D, Tebbutt NC, Simes RJ, Chalchal H, Shapiro JD, Robitaille S, Price TJ, Shepherd L, Au HJ, Langer C, Moore MJ, Zalcberg JR. Karapetis CS, et al. Among authors: price tj. N Engl J Med. 2008 Oct 23;359(17):1757-65. doi: 10.1056/NEJMoa0804385. N Engl J Med. 2008. PMID: 18946061 Clinical Trial.
A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma.
Lewis KD, Robinson WA, Millward MJ, Powell A, Price TJ, Thomson DB, Walpole ET, Haydon AM, Creese BR, Roberts KL, Zalcberg JR, Gonzalez R. Lewis KD, et al. Among authors: price tj. Invest New Drugs. 2008 Feb;26(1):89-94. doi: 10.1007/s10637-007-9080-5. Epub 2007 Sep 20. Invest New Drugs. 2008. PMID: 17891338 Clinical Trial.
Cetuximab for the treatment of colorectal cancer.
Jonker DJ, O'Callaghan CJ, Karapetis CS, Zalcberg JR, Tu D, Au HJ, Berry SR, Krahn M, Price T, Simes RJ, Tebbutt NC, van Hazel G, Wierzbicki R, Langer C, Moore MJ. Jonker DJ, et al. N Engl J Med. 2007 Nov 15;357(20):2040-8. doi: 10.1056/NEJMoa071834. N Engl J Med. 2007. PMID: 18003960 Clinical Trial.
Management and survival trends in advanced colorectal cancer.
Price T, Pittman K, Patterson W, Colbeck M, Rieger N, Hewett P, Rodda D, Townsend A, Maddern G, Luke C, Roder D. Price T, et al. Clin Oncol (R Coll Radiol). 2008 Oct;20(8):626-30. doi: 10.1016/j.clon.2008.04.014. Epub 2008 Jun 3. Clin Oncol (R Coll Radiol). 2008. PMID: 18524553
351 results